The Mesothelioma Guide Blog

Checkpoint inhibitor immunotherapy works for malignant mesothelioma, specifically when the disease forms near the lungs. There’s another type of mesothelioma, usually...

After 15 years of not approving any new therapies for mesothelioma, the U.S. Food and Drug Administration approved two in consecutive years. The FDA green-lit a tumor treating...

Doctors are constantly looking for indicators of mesothelioma survival. Stage, patient’s age, cell type and overall health are the most obvious ones. Then there are protein...

Mesothelioma often withstands chemotherapy, making the treatment ineffective for patients. A new study may reveal just why this happens — and if there’s a way to avoid...

Linda Reinstein, the CEO and co-founder of the Asbestos Disease Awareness Organization, offered the message of hope. She said the Alan Reinstein Ban Asbestos Now Act, the...

Asbestos is a counteragent for heat. Therefore, it made sense to use asbestos anywhere heat was a concern: homes, offices, Navy ships, automobiles and more. Aluminum smelting...

A promising immunotherapy drug for mesothelioma is entering the most important phase of the FDA approval process. The upcoming phase 3 DREAM3R clinical trial presents durvalumab...

Doctors may have a new, more tolerable way to deliver mesothelioma chemotherapy — all thanks to a dog. Researchers reported on a case of mesothelioma in a canine. The canine had...

Immunotherapy works for mesothelioma, just not in every case. The goal is to determine who will benefit from this emerging therapy — and who won’t. The National Cancer...